New ways are needed to manage supplier chains effectively. Here, the instrument of a ‘limited life company’ is suggested. It seems to have several benefits.
No takes yet. Share an insight, caveat, or question.
Richard Hall (1999) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: